Korean J Physiol Pharmacol.
1997 Jun;1(3):225-231.
Interaction of forskolin with the effect of N-6-cyclopentyladenosine on
norepinephrine release in rat hippocampus
- Affiliations
-
- 1Department of Pharmacology and Anesthesiology, Wonkwang University, School
of Medicine, Iksan 570-749 South Korea.
- 2Medicinal Resources Research Center of Wonkwang University, Iksan 570-749, Korea.
Abstract
-
As it has been reported that the depolarization-induced norepinephrine
(NE) release is modulated by activation of presynaptic A-1-adenosine
heteroreceptor and various lines of evidence indicate the involvement
of adenylate cyclase system in A-1-adenosine post-receptor mechanism in
hippocampus, it was attempted to delineate the role of adenylate
cyclase system in the A-1-receptor-mediated control of NE release in
this study. Slices from rat hippocampus were equilibrated with (3H)-NE
and the release of the labelled products was evoked by electrical
stimulation (3 Hz, 5 V cm-1, 2 ms, rectangular pulses). The influence
of various agents on the evoked tritium-outflow was investigated.
N-6-Cyclopentyladenosine (CPA), a specific A-1-adenosine receptor
agonist, in concentrations ranging from 0.1 to 10 micrometer decreased the
(3H)-NE release in a dose-dependent manner without any change of basal
rate of release. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX, 2 micrometer), a
selective A-1-receptor antagonist, inhibited the CPA effect. The
responses to N-ethylmaleimide (3 & 10 micrometer), a SH-alkylating agent of
G-protein, were characterized by increments of the evoked NE-release
and the CPA effects were completely abolished by NEM pretreatment.
Forskolin, a specific adenylate cyclase activator, in concentrations
ranging from 0.1 to 30 micrometer increased the evoked and basal rate of NE
release in a dose-dependent manner and the CPA effects were inhibited
by forskolin pretreatment. Rolipram (1 & 10 micrometer), a phosphodiesterase
inhibitor, did not affect the evoked NE release, but reduced the CPA
effect. And 8-bromo-cAMP (100 & 300 micrometer), a membrane permeable cAMP
analogue, inhibited the CPA effect significantly. These results suggest
that the A-1-adenosine heteroreceptor plays an important role in
NE-release via nucleotide-binding protein G-i in the rat hippocampus
and that the adenylate cyclase system might be participated in this
process.